Jasper Therapeutics Inc. (NASDAQ: JSPR)
$21.9350
+0.0950 ( -0.07% ) 44.0K
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Market Data
Open
$21.9350
Previous close
$21.8400
Volume
44.0K
Market cap
$328.61M
Day range
$21.1660 - $23.0000
52 week range
$4.0000 - $31.0100
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Apr 22, 2024 |
def | Proxies and info statements | 3 | Apr 22, 2024 |
4 | Insider transactions | 1 | Mar 12, 2024 |
10-k | Annual reports | 100 | Mar 05, 2024 |
8-k | 8K-related | 17 | Mar 04, 2024 |
4 | Insider transactions | 1 | Feb 20, 2024 |
4 | Insider transactions | 1 | Feb 20, 2024 |
4 | Insider transactions | 1 | Feb 20, 2024 |
4 | Insider transactions | 1 | Feb 20, 2024 |
4 | Insider transactions | 2 | Feb 12, 2024 |